Skip to main content

Breast Cancer Research and Treatment

Ausgabe 3/2011

Inhalt (33 Artikel)

Preclinical study

RACK1 promotes breast carcinoma migration/metastasis via activation of the RhoA/Rho kinase pathway

Xi-Xi Cao, Jing-Da Xu, Jia-Wen Xu, Xiao-Li Liu, Yuan-Yuan Cheng, Qing-Quan Li, Zu-De Xu, Xiu-Ping Liu

Preclinical study

miR-17-5p promotes human breast cancer cell migration and invasion through suppression of HBP1

Hongling Li, Chunjing Bian, Lianming Liao, Jing Li, Robert Chunhua Zhao

Preclinical study

Involvement of PKC delta (PKCδ) in the resistance against different doxorubicin analogs

María Ines Díaz Bessone, Damian E. Berardi, Paola B. Campodónico, Laura B. Todaro, Leonard Lothstein, Elisa D. Bal de Kier Joffé, Alejandro J. Urtreger

Preclinical study

Classical membrane progesterone receptors in murine mammary carcinomas: agonistic effects of progestins and RU-486 mediating rapid non-genomic effects

María Cecilia Bottino, Juan Pablo Cerliani, Paola Rojas, Sebastián Giulianelli, Rocío Soldati, Carolina Mondillo, María Alicia Gorostiaga, Omar P. Pignataro, Juan Carlos Calvo, J. Silvio Gutkind, Panomwat Amornphimoltham, Alfredo A. Molinolo, Isabel A. Lüthy, Claudia Lanari

Clinical trial

The value of preoperative staging chest computed tomography to detect asymptomatic lung and liver metastasis in patients with primary breast carcinoma

Hyeyoung Kim, Wonshik Han, Hyeong-Gon Moon, Junwon Min, Soo-Kyung Ahn, Tae-You Kim, Seock-Ah Im, Do-Youn Oh, Sae-Won Han, Eui Kyu Chie, Sung Whan Ha, Dong-Young Noh

Clinical trial

Tumor angiogenesis as prognostic and predictive marker for chemotherapy dose-intensification efficacy in high-risk breast cancer patients within the WSG AM-01 trial

Oleg Gluz, Peter Wild, Cornelia Liedtke, Ronald Kates, Heiko Mendrik, Elisabeth Ehm, Verena Artinger, Raihanatou Diallo-Danebrock, Evelyn Ting, Svjetlana Mohrmann, Christopher Poremba, Nadia Harbeck, Ulrike Nitz, Arndt Hartmann, Andreas Gaumann

Epidemiology

Association between mitogen-activated protein kinase kinase kinase 1 rs889312 polymorphism and breast cancer risk: evidence from 59,977 subjects

Pei-Hua Lu, Jie Yang, Chen Li, Mu-Xin Wei, Wei Shen, Li-ping Shi, Zhi-Yang Jiang, Ning Zhou, Guo-Qing Tao

Epidemiology

Family history of breast cancer in first-degree relatives and triple-negative breast cancer risk

Amanda I. Phipps, Diana S. M. Buist, Kathleen E. Malone, William E. Barlow, Peggy L. Porter, Karla Kerlikowske, Christopher I. Li

Epidemiology

Bone mineral density and risk of postmenopausal breast cancer

Debjani Grenier, Andrew L. Cooke, Lisa Lix, Colleen Metge, Huimin Lu, William D. Leslie

Epidemiology

Let-7a regulation of insulin-like growth factors in breast cancer

Lingeng Lu, Dionyssios Katsaros, Yong Zhu, Aaron Hoffman, Scarampi Luca, Canuto Emilie Marion, Lina Mu, Harvey Risch, Herbert Yu

Epidemiology

Concurrent use of tamoxifen with CYP2D6 inhibitors and the risk of breast cancer recurrence

Laurent Azoulay, Sophie Dell’Aniello, Laetitia Huiart, Guillaume Galbaud du Fort, Samy Suissa

Epidemiology

Spectrum of BRCA1/2 point mutations and genomic rearrangements in high-risk breast/ovarian cancer Chilean families

Patricio Gonzalez-Hormazabal, Sara Gutierrez-Enriquez, Daniel Gaete, Jose M. Reyes, Octavio Peralta, Enrique Waugh, Fernando Gomez, Sonia Margarit, Teresa Bravo, Rafael Blanco, Orland Diez, Lilian Jara

Epidemiology

A combined analysis of genome-wide association studies in breast cancer

Jingmei Li, Keith Humphreys, Tuomas Heikkinen, Kristiina Aittomäki, Carl Blomqvist, Paul D. P. Pharoah, Alison M. Dunning, Shahana Ahmed, Maartje J. Hooning, John W. M. Martens, Ans M. W. van den Ouweland, Lars Alfredsson, Aarno Palotie, Leena Peltonen-Palotie, Astrid Irwanto, Hui Qi Low, Garrett H. K. Teoh, Anbupalam Thalamuthu, Douglas F. Easton, Heli Nevanlinna, Jianjun Liu, Kamila Czene, Per Hall

Epidemiology

Increased risk of contralateral breast cancers among overweight and obese women: a time-dependent association

Bilal Majed, Adrien Dozol, Laureen Ribassin-Majed, Kamel Senouci, Bernard Asselain

Epidemiology

Role of ethnic variations in TNF-α and TNF-β polymorphisms and risk of breast cancer in India

Singh Pooja, Amirtharaj Francis, Hemant Kumar Bid, Sandeep Kumar, Singh Rajender, K. Ramalingam, Kumarasamy Thangaraj, Rituraj Konwar

Epidemiology

Age-related variation in the relationship between menopausal hormone therapy and the risk of dying from breast cancer

Kerryn W. Reding, David R. Doody, Anne McTiernan, Li Hsu, Scott Davis, Janet R. Daling, Peggy L. Porter, Kathleen E. Malone

Epidemiology

Polymorphisms of tumor necrosis factor-alpha and breast cancer risk: a meta-analysis

Chao Shen, Haiming Sun, Donglin Sun, Lidan Xu, Xuelong Zhang, An Liu, Xueyuan Jia, Jing Bai, Feng Chen, Yang Yu, Yan Jin, Jingcui Yu, Songbin Fu

Epidemiology

Mutations in BRCA2 and PALB2 in male breast cancer cases from the United States

Yuan Chun Ding, Linda Steele, Chih-Jen Kuan, Scott Greilac, Susan L. Neuhausen

Brief Report

Tetra-methoxystilbene modulates ductal growth of the developing murine mammary gland

Taehyun Kim, Hoyong Park, Wei Yue, Ji-Ping Wang, Kristen A. Atkins, Zhenguo Zhang, Eleanor G. Rogan, Ercole L. Cavalieri, Khalid S. Mohammad, Sanghee Kim, Richard J. Santen, Sarah E. Aiyar

Brief Report

Classification of breast cancer precursors through exhaled breath

Gregory Shuster, Zahava Gallimidi, Asnat Heyman Reiss, Ekaterina Dovgolevsky, Salem Billan, Roxolyana Abdah-Bortnyak, Abraham Kuten, Ahuva Engel, Ala Shiban, Ulrike Tisch, Hossam Haick

Brief Report

The effects of oncotype DX recurrence scores on chemotherapy utilization in a multi-institutional breast cancer cohort

Foluso O. Ademuyiwa, Austin Miller, Tracey O’Connor, Stephen B. Edge, Mangesh A. Thorat, George W. Sledge, Ellis Levine, Sunil Badve

Short Communication

Paraneoplastic polymyositis associated with breast cancer: a therapeutic emergency

S. Croce, M. Guèye, A. C. E. Korganow, E. Chatelus, S. M. K. Guèye, P. Diemunsch, C. Mathelin

Letter to the Editor

Significant association between ABCB1 gene C3435T polymorphism and breast cancer risk

Jun Wang, Baocheng Wang, Jingwang Bi

Letter to the Editor

PALB2 germline mutations in familial breast cancer cases with personal and family history of pancreatic cancer

Paolo Peterlongo, Irene Catucci, Graziella Pasquini, Paolo Verderio, Bernard Peissel, Monica Barile, Liliana Varesco, Mirko Riboni, Stefano Fortuzzi, Siranoush Manoukian, Paolo Radice

Letter to the Editor

Catechol-O-methyltransferase Val158Met polymorphism in breast cancer risk

Bo Xi, Tao Zeng, Weina Liu

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.